From September @ to July @ , @ patients < @ years old with stage I-IIA with bulk , I-IIAE , I-IIB , and IIIA-IVA with or without doxorubicin , bleomycin , vincristine , etoposide , prednisone , and cyclophosphamide were enrolled .